Nykredit A/S »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Nykredit A/S

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Nykredit A/S from 13F filings

Historical chart of Nykredit A/S investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Nykredit A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Nykredit A/S

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 1.5M 1.47

More positions owned by Nykredit A/S

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Citigroup Com New (C)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Tesla Motors (TSLA)
Travelers Companies (TRV)

View all positions for Nykredit A/S

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Citadel Advisors
LMR Partners
Point72 Asset Management
Tenor Capital Management
Alberta Investment Management Corporation
Lombard Odier Asset Management
Millennium Management
Lazard Asset Management
Absolute Investment Advisers
Linden Advisors
Calamos Advisors
BlackRock
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1